MEDIPOST announced that it got a patent registered in the United States for treating cancer using stem cells.

The biotechnology company said that it received the patent from the United States Patents and Trademark Office for the technology it developed, which treats patients by combining cancer-repressing genes with cord blood stem cells. The company also had patents registered in a number of European countries in March for this technology.

The company explained that it can be used to track diverse cancers including those in the brain, breasts, and rectal passage, and expressed hope that it can also be applied in the development of a cure for Alzheimer’s disease.